These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1751607)

  • 21. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
    Lin CY; Lin CC; Huang TP
    Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritonitis, pancreatitis, and infected pseudocyst in a continuous ambulatory peritoneal dialysis patient.
    Singh S; Wadhwa N
    Am J Kidney Dis; 1987 Jan; 9(1):84-6. PubMed ID: 3812483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.
    Weber J; Staerz E; Mettang T; Machleidt C; Kuhlmann U
    Perit Dial Int; 1989; 9(3):191-5. PubMed ID: 2488364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous ambulatory peritoneal dialysis-associated peritonitis as a model device-related infection: phenotypic adaptation, the staphylococcal cell envelope and infection.
    Williams P; Swift S; Modun B
    J Hosp Infect; 1995 Jun; 30 Suppl():35-43. PubMed ID: 7560971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis.
    de Fijter CW; Oe LP; Heezius EC; Donker AJ; Verbrugh HA
    Am J Kidney Dis; 1996 Mar; 27(3):409-15. PubMed ID: 8604711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilm formation and changes in bacterial cell surface hydrophobicity during growth in a CAPD model system.
    Hanlon GW; Denyer SP; Hodges NA; Brant JA; Lansley AB; Al-Rustamani WA
    J Pharm Pharmacol; 2004 Jul; 56(7):847-54. PubMed ID: 15233862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generalized lymphadenopathy in continuous ambulatory peritoneal dialysis patients associated with Staphylococcus epidermidis infection.
    Pollock CA; Ibels LS
    Nephron; 1989; 52(1):81-2. PubMed ID: 2710271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study.
    Muñoz de Bustillo E; Aguilera A; Jiménez C; Bajo MA; Sánchez C; Selgas R
    Perit Dial Int; 1997; 17(4):392-5. PubMed ID: 9284469
    [No Abstract]   [Full Text] [Related]  

  • 29. Colonization of skin and development of peritonitis due to coagulase-negative staphylococci in patients undergoing peritoneal dialysis.
    Eisenberg ES; Ambalu M; Szylagi G; Aning V; Soeiro R
    J Infect Dis; 1987 Sep; 156(3):478-82. PubMed ID: 3611833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
    Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dialysate fluids on phagocytosis and killing by normal neutrophils.
    Harvey DM; Sheppard KJ; Morgan AG; Fletcher J
    J Clin Microbiol; 1987 Aug; 25(8):1424-7. PubMed ID: 3624441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of methods for processing dialysate in suspected continuous ambulatory peritoneal dialysis-associated peritonitis.
    Woods GL; Washington JA
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):155-7. PubMed ID: 3652654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of causative pathogen of peritonitis using in-situ hybridization in a patient with continuous ambulatory peritoneal dialysis.
    Ota K; Maruyama H; Iino N; Nakamura G; Shimotori M; Tanabe Y; Tsukada H; Gejyo F
    J Infect Chemother; 2007 Aug; 13(4):273-5. PubMed ID: 17721693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) by Y-connected double bag systems.
    Wüst J; Binswanger U; Bichsel G
    Life Support Syst; 1985; 3 Suppl 1():107-11. PubMed ID: 3870548
    [No Abstract]   [Full Text] [Related]  

  • 39. Opsonic requirements of Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
    Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
    Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.